Nuvectis Pharma, Inc. (NVCT) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$16.01M | -30.7% |
| 2024 | -$12.25M | +23.2% |
| 2023 | -$15.95M | -17.7% |
| 2022 | -$13.56M | -42.7% |
| 2021 | -$9.50M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$16.01M | -30.7% |
| 2024 | -$12.25M | +23.2% |
| 2023 | -$15.95M | -17.7% |
| 2022 | -$13.56M | -42.7% |
| 2021 | -$9.50M | — |